Silver Book Fact

Effectiveness of treating ischemic strokert-PA within 3 hours of symptom onset

A study of the  victims with effectiveness of treating ischemic strokert-PA within 3 hours of symptom onset showed a decrease in rehabilitation costs of $1.4 million and nursing home costs of $4.8 million, per 1,000 eligible rt-PA-treated patients.

Fagan S, Morgenstern L, Petitta A, Ward R, et al. Cost-Effectiveness of Tissue Plasminogen Activator for Acute Ischemic Stroke. Neurology. 1998; 50(4): 883-890. http://www.neurology.org/content/50/4/883.abstract

Reference

Title
Cost-Effectiveness of Tissue Plasminogen Activator for Acute Ischemic Stroke
Publication
Neurology
Publication Date
1998
Authors
Fagan S, Morgenstern L, Petitta A, Ward R, et al.
Volume & Issue
Volume 50, Issue 4
Pages
883-890
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Per-patient annual cost of treating stroke in atrial fibrillation patients
    The per-patient annual cost of treating stroke in atrial fibrillation patients was found to be $1,485 in a wellcontrolled anti-coagulation clinic, $3,710 for those receiving warfarin in routine medical care,…  
  • Effectiveness of treating ischemic stroke victims with rt-PA within 3 hours of symptom onset
    A study of the effectiveness of treating ischemic stroke victims with rt-PA within 3 hours of symptom onset found an estimated impact on long-term health outcomes of 564 quality-adjusted life-years saved…  
  • Primary angioplasty reduces 30-day mortality risk by 34% to 50%.  
  • Cost-savings associated with Warfarin use in AFib patients
    Warfarin use in Medicare patients with nonvalvular atrial fibrillation was independently associated with lower medical costs averaging $9,836 per patient, per year.  
  • Compared to standard coverage, 3 years of full coverage for prevention medications will reduce mortality and reinfarction rates and will save $5,974 per patient.